Clinical Trial Update: Spasmodic Dysphonia Pain [Phase 2, Phase 3]

View source ↗

Summary

This document reports a clinical trial update for Spasmodic Dysphonia involving Phase 2 and Phase 3 studies. Results were posted on 2024-05-23 after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasmodic Dysphonia

Snippet

Sponsor: Mayo Clinic | Conditions: Spasmodic Dysphonia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-05-23